Headache as a presenting feature in patients with serotonin syndrome: A case series

Cephalalgia

Volumn 34, Issue 2, 2014, Pages 148-153

  Prakash, Sanjay ^a   Belani, Pooja ^a   Trivedi, Aditi ^a  

^a Baroda Medical College   (India)

Author keywords

antidepressant; drug induced headache; Headache; serotonin; serotonin syndrome

Indexed keywords

CLONAZEPAM; CYPROHEPTADINE; FLUOXETINE; ONDANSETRON; PARACETAMOL PLUS TRAMADOL; PAROXETINE;

ADULT; AGITATION; ANKLE SPRAIN; ANXIETY DISORDER; BEHAVIOR DISORDER; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CLONUS; DEPRESSION; DIAPHORESIS; DISEASE DURATION; DISEASE EXACERBATION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; ELEVATED BLOOD PRESSURE; FEMALE; FEVER; FOLLOW UP; HAND TREMOR; HUMAN; HUNTER SEROTONIN TOXICITY CRITERIA; HYPERREFLEXIA; LOW BACK PAIN; MALE; MEDICAL HISTORY; MIDDLE AGED; MUSCLE RIGIDITY; MYDRIASIS; NAUSEA; NAUSEA AND VOMITING; OUTPATIENT DEPARTMENT; PHOTOPHOBIA; PHYSICAL ACTIVITY; PSYCHIATRIST; RESTLESSNESS; REVIEW; SEROTONIN SYNDROME; SLEEP DISORDER; SWEAT GLAND DISEASE; TACHYCARDIA; TOXICITY TESTING; TREATMENT DURATION; YOUNG ADULT;

ANTIDEPRESSANT; DRUG-INDUCED HEADACHE; HEADACHE; SEROTONIN; SEROTONIN SYNDROME;

ADULT; ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS; FEMALE; HEADACHE; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; SEROTONIN; SEROTONIN AGENTS; SEROTONIN SYNDROME; TRAMADOL; YOUNG ADULT;

EID: 84892168932     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413495968     Document Type: Review

References (32)

1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005; 352: 1112-1120
2. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991; 148: 705-713
3. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: Simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003; 96: 635-642
4. Radomski JW, Dursun SM, Reveley MA, et al. An exploratory approach to the serotonin syndrome: An update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses. 2000; 55: 218-224
5. Richard IH, Kurlan R, Tanner C, et al. Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group. Neurology. 1997; 48: 1070-1077
6. Terao T, Hikichi T. Serotonin syndrome in a case of depression with various somatic symptoms: The difficulty in differential diagnosis. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31: 295-296
7. Alnwick GM. Misdiagnosis of serotonin syndrome as fibromyalgia and the role of physical therapists. Phys Ther. 2008; 88: 757-765
8. Ferrari A. Headache: One of the most common and troublesome adverse reactions to drugs. Curr Drug Saf. 2006; 1: 43-58
9. Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs. 1999; 57: 507-533
10. Wernicke JF. Safety and side effect profile of fluoxetine. Expert Opin Drug Saf. 2004; 3: 495-504
11. Sinclair LI, Christmas DM, Hood SD, et al. Antidepressant-induced jitteriness/anxiety syndrome: Systematic review. Br J Psychiatry. 2009; 194: 483-490
12. Marcy TR, Britton ML. Antidepressant-induced sweating. Ann Pharmacother. 2005; 39: 748-752
13. Schillevoort I, van Puijenbroek EP, de Boer A, et al. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: A case-control study using spontaneous reports. Int Clin Psychopharmacol. 2002; 17: 75-79
14. Marks DM, Park MH, Ham BJ, et al. Paroxetine: Safety and tolerability issues. Expert Opin Drug Saf. 2008; 7: 783-794
15. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004; 43: 879-923
16. Wilder-Smith CH, Schimke J, Osterwalder B, et al. Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain. Ann Oncol. 1994; 5: 141-146
17. Spiller HA, Gorman SE, Villalobos D, et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol. 1997; 35: 361-364
18. Ossowska K, Wolfarth S. Muscle rigidity induced by the opioid analgesic tramadol, but not by the non-opioid flupurtine. Pol J Pharmacol. 1994; 46: 61-65
19. Fortney JT, Gan TJ, Graczyk S, et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Anesth Analg. 1998; 86: 731-738
20. Simpson KH, Hicks FM. Clinical pharmacokinetics of ondansetron. A review. J Pharm Pharmacol. 1996; 48: 774-781
21. Rice GP, Lesaux J, Vandervoort P, et al. Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor. J Neurol Neurosurg Psychiatry. 1997; 62: 282-284
22. Sommer C. Serotonin in pain and pain control. In: Müller C and Jacobs B (eds) Handbook of behavioral neurobiology of serotonin. London, Burlington, San Diego: Academic Press, 2010, pp.457-471.
23. Turkel SB, Nadala JG, Wincor MZ. Possible serotonin syndrome in association with 5-HT3 antagonist agents. Psychosomatics. 2001; 42: 258-260
24. Gollapudy S, Kumar V, Dhamee MS. A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion. J Clin Anesth. 2012; 24: 251-252
25. Evans RW, Tepper SJ, Shapiro RE, et al. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors; American Headache Society Position Statement. Headache. 2010; 50: 1089-1099
26. Srikiatkhachorn A, Govitrapons P, Limthavon C. Up-regulation of 5-HT2 serotonin receptor: A possible mechanism of transformed migraine. Headache. 1994; 34: 8-11
27. Srikiatkhachorn A, Anthony M. Serotonin receptor adaptation in patients with analgesic-induced headache. Cephalalgia. 1996; 16: 419-422
28. Srikiatkhachorn A, Puangniyom S, Govitrapong P. Plasticity of 5-HT2A serotonin receptor in patients with analgesic-induced transformed migraine. Headache. 1998; 38: 534-539
29. Srikiatkhachorn A, Suwattanasophon C, Ruangpattanatawee U, et al. 2002 Wolff Award. 5-HT2A receptor activation and nitric oxide synthesis: A possible mechanism determining migraine attacks. Headache. 2002; 42: 566-574
30. Rao BS, Das DG, Taraknath VR, et al. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Neurol India. 2000; 48: 223-226
31. Da Costa AR, Monzillo PH, Sanvito WL. Use of chlorpromazine in the treatment of headache at an emergency service. Arq Neuropsiquiatr. 1998; 56: 565-568
32. Silberstein SD, Peres MF, Hopkins MM, et al. Olanzapine in the treatment of refractory migraine and chronic daily headache. Headache. 2002; 42: 515-518